According to blogger Tom Wilson, co-founder and president of The CareGiver Partnership and former Kimberly-Clark executive, Procter & Gamble may be readying to re-enter the incontinence market as soon as this summer.
Pure Encapsulations recently launched PureBiOme, a line of probiotics using proprietary PureBiOme freeze-drying technology, which enables probiotics to maintain potency when combined with active ingredients for the first time.
Although the pace of approvals for new orphan drugs — medicines that treat relatively rare conditions — have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study released last week by the Tufts Center for the Study of Drug Development at Tufts University has concluded.
Teva Pharmaceuticals on Monday announced that the Food and Drug Administration has accepted the company's new drug application for albuterol multi-dose dry-powder inhaler, a breath-actuated dry-powder inhaler for the treatment or prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease.
AmerisourceBergen Technology Group on Thursday launched FastPak Elite, a tool that "reinvents the pouch packager to meet the demands of high-volume pharmacy operations, by putting medications in convenient multidose packaging," the company stated.
Anacor Pharmaceuticals announced that the Food and Drug Administration has approved the company's new drug application for Kerydin (tavaborole) topical solution, 5% — an antifungal approved for the topical treatment of onychomycosis of the toenails.
Lake Consumer Products, a subsidiary of Wisconsin Pharmacal Co., on Thursday acquired the exclusive North American rights to an over-the-counter product that addresses many of the key symptoms associated with premenstrual syndrome.